Patil Vijay M, Noronha Vanita, Joshi Amit, Banavali Sripad D, Muddu Vamshi, Prabhash Kumar
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Oncology. 2016;91 Suppl 1:35-40. doi: 10.1159/000447579. Epub 2016 Jul 28.
Locally advanced oral cavity cancers are treated with a multi-modality approach. Surgery is the most efficient local modality in comparison to chemoradiation in oral cancers. Preoperative chemotherapy has failed its expectations to improve disease-free survival or overall survival in resectable oral cancers. Its use as an organ preservation tool is being studied. Induction chemotherapy followed by assessment for surgery is an appropriate option for borderline resectable or technically unresectable oral cancer. Metronomic chemotherapy is being studied as a bridge to surgery and as adjuvant chemotherapy in locally advanced oral cancers. The role of induction chemotherapy in unresectable oral cancers is unproven. Metronomic chemotherapy has shown improved progression-free survival and overall survival in oral cancers in comparison to intravenous cisplatin. A phase 3 study for confirmation of this finding has begun.
局部晚期口腔癌采用多模式方法治疗。与口腔癌的放化疗相比,手术是最有效的局部治疗方式。术前化疗未能达到改善可切除口腔癌无病生存期或总生存期的预期。其作为器官保留工具的用途正在研究中。对于边界可切除或技术上不可切除的口腔癌,先进行诱导化疗然后评估是否手术是一种合适的选择。小剂量节拍化疗正在作为局部晚期口腔癌手术的桥梁和辅助化疗进行研究。诱导化疗在不可切除口腔癌中的作用尚未得到证实。与静脉注射顺铂相比,小剂量节拍化疗已显示出可改善口腔癌的无进展生存期和总生存期。一项证实这一发现的3期研究已经开始。